Practice Advantage

Expanding AMD Care with Genetic Testing with Scott Rediger and Dr. Steve Ferrucci

Episode Summary

Expanding AMD care is a significant opportunity for private practices across the country. Scott Rediger and Dr. Steve Ferrucci share tips for expanding AMD by successfully adding genetic testing.

Episode Notes

On today's episode, I sit down with Scott Rediger, CEO of Visible Genomics, and Dr. Steve Ferrucci, well known optometrist, lecturer, and clinical expert to discuss the power of genetic testing and the business opportunity for expanding AMD care within your practice. 

Key Takeaways:

  1. Always be open to input from others.
  2. The opportunity for AMD in the United States is significant. 11 million are currently living with AMD and 20 million are at risk due to genetic and lifestyle risk factors. AMD is an untapped market in your practice.
  3. AMD revenue opportunities include: Selling nutraceuticals, providing genetic testing, ongoing testing as part of management, at home monitoring, and dark adaptation
  4. Like any additional service, success requires involving your entire team to engage the process and communicate the test and benefits appropriately to the patient. Telehealth can be a phenomenal tool for follow up, creating a better patient experience and minimizing time for both patient and doctor.
  5. Don’t be afraid of the cost. Connect the value of personalized care to their long term outcome, and the cost conversation becomes much easier.

Take your practice to the next level with PECAA Max!

What Steve is Reading:

What Scott is Reading: